Clinical Trial Update: Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer

View source ↗

Summary

This clinical trial update investigates how prevalent Alpha-1-antitrypsin deficiency is among patients with hepatocellular carcinoma arising in non-cirrhotic li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Hepatocellular Carcinoma

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Retrospective Cohort of Patients Diagnosed With HCC on Non-Cirrhotic Liver | Status: NOT_YET_RECRUITING